Daniel Knobeloch

933 total citations
13 papers, 748 citations indexed

About

Daniel Knobeloch is a scholar working on Hepatology, Surgery and Pharmacology. According to data from OpenAlex, Daniel Knobeloch has authored 13 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Daniel Knobeloch's work include Liver physiology and pathology (8 papers), 3D Printing in Biomedical Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Daniel Knobeloch is often cited by papers focused on Liver physiology and pathology (8 papers), 3D Printing in Biomedical Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Daniel Knobeloch collaborates with scholars based in Germany, United States and Sweden. Daniel Knobeloch's co-authors include Andreas K. Nüssler, Katrin Zeilinger, Jörg C. Gerlach, Marc Lübberstedt, Ursula Müller‐Vieira, Klaus M. Biemel, Daniel Feurstein, Andreas Fischer, Daniel R. Dietrich and Fanny Knöspel and has published in prestigious journals such as Biotechnology and Bioengineering, Toxicology and Applied Pharmacology and Alcoholism Clinical and Experimental Research.

In The Last Decade

Daniel Knobeloch

13 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Knobeloch Germany	10	253	232	217	186	149	13	748
Juan Zhou China	18	60 0.2×	13 0.1×	598 2.8×	95 0.5×	102 0.7×	52	913
Yuan H. Wen China	11	22 0.1×	19 0.1×	134 0.6×	108 0.6×	59 0.4×	20	474
Anke Haugg Germany	11	23 0.1×	33 0.1×	154 0.7×	20 0.1×	33 0.2×	13	627
Sylvie Masson France	15	40 0.2×	142 0.6×	135 0.6×	21 0.1×	22 0.1×	23	490
Jingtao Lu China	15	51 0.2×	73 0.3×	308 1.4×	95 0.5×	5 0.0×	23	670
Amphun Chaiboonchoe United Arab Emirates	13	35 0.1×	10 0.0×	325 1.5×	25 0.1×	12 0.1×	30	602
Chia-Hung Wu Taiwan	12	10 0.0×	30 0.1×	257 1.2×	31 0.2×	31 0.2×	16	444
Horst‐Dietmar Tauschel Germany	12	10 0.0×	52 0.2×	196 0.9×	14 0.1×	16 0.1×	29	435
Deborah Rijkers Netherlands	11	52 0.2×	12 0.1×	169 0.8×	59 0.3×	204 1.4×	20	496
Marcel van Herwijnen Netherlands	14	40 0.2×	58 0.3×	240 1.1×	110 0.6×	37 0.2×	29	598

Countries citing papers authored by Daniel Knobeloch

Since Specialization

Citations

This map shows the geographic impact of Daniel Knobeloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Knobeloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Knobeloch more than expected).

Fields of papers citing papers by Daniel Knobeloch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Knobeloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Knobeloch. The network helps show where Daniel Knobeloch may publish in the future.

Co-authorship network of co-authors of Daniel Knobeloch

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Knobeloch. A scholar is included among the top collaborators of Daniel Knobeloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Knobeloch. Daniel Knobeloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hoffmann, Stefan A., Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2012). Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies. Biotechnology and Bioengineering. 109(12). 3172–3181. 55 indexed citations

Lübberstedt, Marc, Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2012). Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacologicalin vitrostudies. Journal of Tissue Engineering and Regenerative Medicine. 9(9). 1017–1026. 41 indexed citations

Zeilinger, Katrin, Thomas Schreiter, Malin Darnell, et al.. (2011). Scaling Down of a Clinical Three-Dimensional Perfusion Multicompartment Hollow Fiber Liver Bioreactor Developed for Extracorporeal Liver Support to an Analytical Scale Device Useful for Hepatic Pharmacological In Vitro Studies. Tissue Engineering Part C Methods. 17(5). 549–556. 88 indexed citations

Mueller, Daniel, Georg Tascher, Ursula Müller‐Vieira, et al.. (2011). In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. Journal of Tissue Engineering and Regenerative Medicine. 5(8). e207–e218. 31 indexed citations

Knobeloch, Daniel, Sabrina Ehnert, Lilianna Schyschka, et al.. (2011). Human Hepatocytes: Isolation, Culture, and Quality Procedures. Methods in molecular biology. 806. 99–120. 47 indexed citations

Ehnert, Sabrina, Lilianna Schyschka, Daniel Knobeloch, et al.. (2011). Further characterization of autologous NeoHepatocytes for in vitro toxicity testing. Toxicology in Vitro. 25(6). 1203–1208. 1 indexed citations

Klein, Kathrin, Ute Hofmann, Stephan Riedmaier, et al.. (2010). Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes. Drug Metabolism and Disposition. 38(9). 1589–1597. 78 indexed citations

Ehnert, Sabrina, Daniel Knobeloch, Alexandra Müller, et al.. (2010). NeoHepatocytes From Alcoholics and Controls Express Hepatocyte Markers and Display Reduced Fibrogenic TGF‐β/Smad3 Signaling: Advantage for Cell Transplantation?. Alcoholism Clinical and Experimental Research. 34(4). 708–718. 6 indexed citations

Nüssler, Andreas K., Liping Hao, Daniel Knobeloch, et al.. (2010). Protective Role of HO-1 for Alcohol-Dependent Liver Damage. Digestive Diseases. 28(6). 792–798. 25 indexed citations

10.

Lübberstedt, Marc, Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2010). HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. Journal of Pharmacological and Toxicological Methods. 63(1). 59–68. 180 indexed citations

11.

Fischer, Andreas, Stefan J. Hoeger, Kerstin Stemmer, et al.. (2010). The role of organic anion transporting polypeptides (OATPs/SLCOs) in the toxicity of different microcystin congeners in vitro: A comparison of primary human hepatocytes and OATP-transfected HEK293 cells. Toxicology and Applied Pharmacology. 245(1). 9–20. 161 indexed citations

12.

Knobeloch, Daniel, Andrea Schmidt, Patrick Scheerer, et al.. (2009). A coleopteran triosephosphate isomerase: X‐ray structure and phylogenetic impact of insect sequences. Insect Molecular Biology. 19(1). 35–48. 6 indexed citations

13.

Jia, Dong, Carl‐Fredrik Mandenius, Marc Lübberstedt, et al.. (2008). Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology. Cytotechnology. 57(3). 251–261. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact